Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSC in Healthy Volunteers Exercising at Altitude
NCT05036980Phase 1Completed
- Sponsor
- Diffusion Pharmaceuticals Inc.
- Start
- Nov 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of trans sodium crocetinate in hypoxia (3 cohorts), sponsored by Diffusion Pharmaceuticals Inc. Primary endpoints: Partial Pressure of Oxygen and Maximal Oxygen Consumption up to 33 minutes. Started Nov 2021; status: completed.
02
Drugs
trans sodium crocetinate
03
Conditions
hypoxia
Beyond the preview
Go deeper on NCT05036980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05036980.